{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:38:17Z","timestamp":1777955897211,"version":"3.51.4"},"reference-count":115,"publisher":"Elsevier","isbn-type":[{"value":"9780443430114","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.pbr.2025.08.007","type":"book-chapter","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T11:09:22Z","timestamp":1756465762000},"page":"277-318","source":"Crossref","is-referenced-by-count":1,"title":["Personalized management of Parkinson\u2019s disease"],"prefix":"10.1016","author":[{"given":"Dipesh","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradyot Kumar","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ria","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chittabrata","family":"Mal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pbr.2025.08.007_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41531-023-00497-x","article-title":"Using a smartwatch and smartphone to assess early Parkinson\u2019s disease in the WATCH-PD study","volume":"9","author":"Adams","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.007_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1212\/01.WNL.0000044047.58984.2F","article-title":"Slowing parkinson\u2019s disease progression: recent dopamine agonist trials","volume":"60","author":"Ahlskog","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/bs.pbr.2025.08.007_bib3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/1570159X16666180830100754","article-title":"Different generations of type-B monoamine oxidase inhibitors in Parkinson\u2019s disease: from bench to bedside","volume":"17","author":"Alborghetti","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"11","key":"10.1016\/bs.pbr.2025.08.007_bib4","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1007\/s10072-024-07659-6","article-title":"Efficacy of cognitive behavioral therapy for anxiety and depression in parkinson\u2019s disease patients: an updated systematic review and meta-analysis","volume":"45","author":"Alnajjar","year":"2024","journal-title":"Neurol. Sci."},{"issue":"12","key":"10.1016\/bs.pbr.2025.08.007_bib5","article-title":"Perioperative management of unexpected placenta percreta in a twin gestation","volume":"16","author":"Alves","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.007_bib6","first-page":"462","article-title":"Advancing deep brain stimulation in Parkinson\u2019s disease: current insights and future directions","volume":"60","author":"Anjum","year":"2024","journal-title":"Medicina"},{"key":"10.1016\/bs.pbr.2025.08.007_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2147\/RMHP.S219294","article-title":"Towards eradication of malaria: is the WHO\u2019s RTS,S\/AS01 vaccination effective enough?","volume":"14","author":"Arora","year":"2021","journal-title":"Risk Manag. Healthc. Policy"},{"key":"10.1016\/bs.pbr.2025.08.007_bib8","unstructured":"Atrain education [Internet]. [cited 2025 May 14].\u00a0Available from: https:\/\/www.atrainceu.com\/content\/2-pathophysiology-parkinson%E2%80%99s-disease."},{"issue":"13","key":"10.1016\/bs.pbr.2025.08.007_bib9","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/mds.22705","article-title":"Major nutritional issues in the management of Parkinson\u2019s disease","volume":"24","author":"Barichella","year":"2009","journal-title":"Mov. Disord."},{"issue":"10423","key":"10.1016\/bs.pbr.2025.08.007_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson\u2019s disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/bs.pbr.2025.08.007_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2019.110717","article-title":"Iron and other metals in the pathogenesis of Parkinson\u2019s disease: toxic effects and possible detoxification","volume":"199","author":"Bj\u00f8rklund","year":"2019","journal-title":"J. Inorg. Biochem."},{"issue":"s1","key":"10.1016\/bs.pbr.2025.08.007_bib12","first-page":"S77","article-title":"Integrated multidisciplinary care for Parkinson\u2019s disease: a call to action","volume":"11","author":"Bloem","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41531-022-00436-2","article-title":"A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson\u2019s disease","volume":"8","author":"Borghammer","year":"2022","journal-title":"NPJ Parkinson\u2019s Dis."},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.007_bib14","first-page":"39","article-title":"Anticholinergic drugs used in Parkinson\u2019s disease: an overlooked class of drugs from a pharmacokinetic perspective","volume":"2","author":"Brocks","year":"1999","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/bs.pbr.2025.08.007_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ptj\/pzaf048","article-title":"Motivation matters: elucidating factors driving exercise in people with Parkinson disease","author":"Cools","year":"2025","journal-title":"Phys. Ther."},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.007_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14740338.2016.1130128","article-title":"A review of adverse events linked to dopamine agonists in the treatment of Parkinson\u2019s disease","volume":"15","author":"Ceravolo","year":"2016","journal-title":"Expert. Opin. Drug. Saf."},{"key":"10.1016\/bs.pbr.2025.08.007_bib17","series-title":"StatPearls [Internet]","article-title":"Amantadine. [Updated 2023 Apr 24]","author":"Chang","year":"2025"},{"issue":"11","key":"10.1016\/bs.pbr.2025.08.007_bib18","first-page":"1735","article-title":"Effects of neuroplasticity-based neurorehabilitation on cognitive and motor function in patients with traumatic brain injury: a systematic review","volume":"36","author":"Chen","year":"2019","journal-title":"J. Neurotrauma."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/CPJ.0000000000000831","article-title":"Genetic testing for Parkinson disease: are we ready?","volume":"11","author":"Cook","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/bs.pbr.2025.08.007_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pneurobio.2018.11.003","article-title":"Exercise as a therapeutic intervention for motor and non-motor symptoms in parkinson\u2019s disease: evidence from rodent models","volume":"172","author":"Crowley","year":"2019","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.007_bib21","first-page":"311","article-title":"Genetic animal models of Parkinson\u2019s disease","volume":"100","author":"Dawson","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/bs.pbr.2025.08.007_bib22","first-page":"43","article-title":"Patient education and self-management in Parkinson\u2019s disease: a systematic review","volume":"96","author":"Deane","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"issue":"8","key":"10.1016\/bs.pbr.2025.08.007_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","article-title":"synTargeting alpha\u2010uclein for treatment of Parkinson\u2019s disease: mechanistic and therapeutic considerations","volume":"14","author":"Dehay","year":"2015","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/bs.pbr.2025.08.007_bib24","article-title":"Virtual reality for rehabilitation in Parkinson\u2019s disease","volume":"12","author":"Dockx","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.007_bib25","first-page":"645","article-title":"Pharmacogenetic testing and healthcare costs in Parkinson\u2019s disease","volume":"20","author":"Dong","year":"2020","journal-title":"Pharmacogenomics J."},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.007_bib26","first-page":"1365","article-title":"Virtual care for Parkinson\u2019s disease: a systematic review","volume":"10","author":"Dorsey","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib27","first-page":"13","article-title":"Precision medicine in Parkinson\u2019s disease: a call to action","volume":"10","author":"Espay","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/bs.pbr.2025.08.007_bib28","series-title":"StatPearls [Internet]","article-title":"Levodopa (L-Dopa) [Internet]","author":"Gandhi","year":"2025"},{"key":"10.1016\/bs.pbr.2025.08.007_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-020-00191-5","article-title":"Freezing of gait in Parkinson\u2019s disease: pathophysiology, risk factors and treatments","volume":"9","author":"Gao","year":"2020","journal-title":"Transl. Neurodegener."},{"issue":"10","key":"10.1016\/bs.pbr.2025.08.007_bib30","first-page":"590","article-title":"Medical management of Parkinson\u2019s disease","volume":"33","author":"Goldenberg","year":"2008","journal-title":"P T"},{"key":"10.1016\/bs.pbr.2025.08.007_bib31","first-page":"1057023","article-title":"Adaptive deep brain stimulation in Parkinson\u2019s disease: a systematic review","volume":"15","author":"Gong","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"8-9","key":"10.1016\/bs.pbr.2025.08.007_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/psb.1940","article-title":"Parkinson\u2019s disease: is pharmacotherapy on the move?","volume":"32","author":"Greener","year":"2021","journal-title":"Prescriber"},{"issue":"10","key":"10.1016\/bs.pbr.2025.08.007_bib33","first-page":"731","article-title":"Parkinson\u2019s disease: pharmacogenetics and treatment response","volume":"20","author":"Grosset","year":"2019","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.007_bib34","first-page":"177","article-title":"RNA interference of LRRK2\u2013microarray expression analysis of a parkinson\u2019s disease key player","volume":"115","author":"H\u00e4big","year":"2008","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/bs.pbr.2025.08.007_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1379243","article-title":"Gait-modifying effects of augmented-reality cueing in people with Parkinson\u2019s disease","volume":"15","author":"Hoogendoorn","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/bs.pbr.2025.08.007_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13063-019-3177-y","article-title":"Evaluating the effect and mechanism of upper limb motor function recovery induced by immersive virtual-reality-based rehabilitation for subacute stroke subjects: study protocol for a randomized controlled trial","volume":"20","author":"Huang","year":"2019","journal-title":"Trials"},{"key":"10.1016\/bs.pbr.2025.08.007_bib37","unstructured":"International Journal of Medical Research & Health Sciences, 2018, 7 (9), 38\u201351."},{"key":"10.1016\/bs.pbr.2025.08.007_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.parkreldis.2021.02.014","article-title":"Clinical manifestations of Parkinson\u2019s disease harboring VPS35 retromer complex component p. D620n with long-term follow-up","volume":"84","author":"Ishiguro","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2025.08.007_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2021.101966","article-title":"Pesticides and Parkinson\u2019s disease: current and future perspective","volume":"115","author":"Islam","year":"2021","journal-title":"J. Chem. Neuroanatomy"},{"key":"10.1016\/bs.pbr.2025.08.007_bib40","first-page":"174","article-title":"Artificial intelligence-driven drug repositioning uncovers efavirenz as a modulator of \u03b1-uclein propagation: implications in Parkinson\u2019s disease","author":"Jae-Bong Kim","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/bs.pbr.2025.08.007_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/21501327211039709","article-title":"The influence of coronavirus disease-2019 (COVID-19) on Parkinson\u2019s disease: an updated systematic review","volume":"12","author":"Jaiswal","year":"2021","journal-title":"J. Prim. Care Community Health"},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.007_bib42","first-page":"729","article-title":"Pharmacogenetics of Parkinson\u2019s disease: implications for clinical practice","volume":"33","author":"Jankovic","year":"2018","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/bs.pbr.2025.08.007_bib43","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s11064-004-6884-y","article-title":"NMDA receptor in nucleus accumbens is implicated in morphine withdrawal in rats","volume":"29","author":"Ji","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/bs.pbr.2025.08.007_bib44","series-title":"StatPearls [Internet]","article-title":"Trihexyphenidyl. [Updated 2024 Jun 8]","author":"Jilani","year":"2025"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib45","doi-asserted-by":"crossref","DOI":"10.2196\/27418","article-title":"The views and needs of people with Parkinson disease regarding wearable devices for disease monitoring: mixed methods exploration","volume":"6","author":"Kenny","year":"2022","journal-title":"JMIR Form. Res."},{"issue":"7732","key":"10.1016\/bs.pbr.2025.08.007_bib46","first-page":"639","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model","volume":"563","author":"Kikuchi","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib47","first-page":"113","article-title":"Genetic variants associated with levodopa-induced dyskinesia in Parkinson\u2019s disease","volume":"38","author":"Kim","year":"2023","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12984-024-01535-2","article-title":"Personalized neurorehabilitation: a review of the current state and future directions","volume":"17","author":"Kim","year":"2020","journal-title":"J. Neuroeng. Rehabil."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib49","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson\u2019s disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"10","key":"10.1016\/bs.pbr.2025.08.007_bib50","first-page":"1724","article-title":"Development and validation of a personalized prognostic model for Parkinson\u2019s disease","volume":"35","author":"Latourelle","year":"2020","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.007_bib51","article-title":"Virtual reality for stroke rehabilitation","volume":"2020","author":"Laver","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.007_bib52","first-page":"427","article-title":"Effects of personalized neurorehabilitation on motor function and cognitive function in patients with stroke: a randomized controlled trial","volume":"34","author":"Lee","year":"2020","journal-title":"Neurorehabil Neural Repair"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib53","first-page":"1","article-title":"Predicting patient outcomes in neurorehabilitation using machine learning algorithms: a systematic review","volume":"20","author":"Lee","year":"2023","journal-title":"J. Neuroeng. Rehabil."},{"key":"10.1016\/bs.pbr.2025.08.007_bib54","series-title":"StatPearls [Internet]","article-title":"Carbidopa. [Updated 2023 Jul 4]","author":"Leyden","year":"2025"},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.007_bib55","first-page":"1275","article-title":"Machine learning for predicting disease progression in Parkinson\u2019s disease: a systematic review","volume":"10","author":"Liu","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.007_bib56","first-page":"333","article-title":"DRD2 gene variants and response to dopamine agonists in Parkinson\u2019s disease","volume":"111","author":"Liu","year":"2022","journal-title":"Clin. Pharmacol. Ther"},{"key":"10.1016\/bs.pbr.2025.08.007_bib57","unstructured":"LiverTox: clinical and research information on drug-induced liver injury [Internet],\u00a02012a. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. Biperiden. [Updated 2017 Jul 20] [cited on 2025b May 02]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548257\/."},{"key":"10.1016\/bs.pbr.2025.08.007_bib58","unstructured":"LiverTox: clinical and research information on drug-induced liver injury [Internet],\u00a02012b. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. Entacapone. [Updated 2021 Oct 25] [cited on 2025a May 02]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548152\/."},{"key":"10.1016\/bs.pbr.2025.08.007_bib59","unstructured":"LiverTox: clinical and research information on drug-induced liver injury [Internet], 2012c. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. Tolcapone. [Updated 2021 Oct 25]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548573\/."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2013.09.007","article-title":"Prevalence and features of peripheral neuropathy in Parkinson\u2019s disease patients under different therapeutic regimens","volume":"20","author":"Mancini","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2025.08.007_bib61","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s10055-024-01065-1","article-title":"A systematic review of techniques and clinical evidence to adopt virtual reality in post-stroke upper limb rehabilitation","volume":"28","author":"Mani Bharathi","year":"2024","journal-title":"Virtual Real."},{"key":"10.1016\/bs.pbr.2025.08.007_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101664","article-title":"Nrf2\/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson\u2019s disease","volume":"36","author":"Marchetti","year":"2020","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/bs.pbr.2025.08.007_bib63","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.2174\/1570159X19666210203162617","article-title":"Patients stratification strategies to optimize the effectiveness of scavenging biogenic aldehydes: towards a neuroprotective approach for Parkinson\u2019s disease","volume":"19","author":"Masato","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/bs.pbr.2025.08.007_bib64","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00702-024-02873-0","article-title":"Test, track, treat using wearable sensors for management of parkinson\u2019s disease: 12-month prospective observational United Arab Emirates study using Parkinson\u2019s kinetograph (EmPark-PKG study)","volume":"132","author":"Metta","year":"2025","journal-title":"J. Neural Transm."},{"key":"10.1016\/bs.pbr.2025.08.007_bib65","series-title":"StatPearls [Internet]","article-title":"Selegiline. [Updated 2023 Aug 17]","author":"Moore","year":"2025"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib66","first-page":"23","article-title":"Rasagiline in treatment of Parkinson\u2019s disease","volume":"4","author":"Nayak","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/bs.pbr.2025.08.007_bib67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.brainresbull.2020.10.011","article-title":"An overview on the mechanisms of neuroprotection and neurotoxicity of isoflurane and sevoflurane in experimental studies","volume":"165","author":"Neag","year":"2020","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib68","first-page":"3","article-title":"Neuroplasticity and neurorehabilitation: a review of the current state and future directions","volume":"33","author":"Nudo","year":"2019","journal-title":"Neurorehabil. Neural Repair"},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.007_bib69","first-page":"147","article-title":"Mesenchymal stem cells inhibit neuroinflammation and improve motor function in a mouse model of Parkinson\u2019s disease","volume":"29","author":"Oh","year":"2020","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/bs.pbr.2025.08.007_bib70","unstructured":"Orphenadrine, 2016. Medline plus. 1 December 2010. Retrieved 6 February 2016."},{"key":"10.1016\/bs.pbr.2025.08.007_bib71","series-title":"StatPearls [Internet]","article-title":"Bromocriptine [Internet]","author":"Ozery","year":"2025"},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.007_bib72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/qjmed\/hcn153","article-title":"Promethazine overdose: clinical effects, predicting delirium and the effect of charcoal","volume":"102","author":"Page","year":"2009","journal-title":"QJM"},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.007_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"12","key":"10.1016\/bs.pbr.2025.08.007_bib74","first-page":"905","article-title":"Adaptive deep brain stimulation for movement disorders: a review","volume":"10","author":"Pi\u00f1a-Fuentes","year":"2020","journal-title":"Brain Sci."},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.007_bib75","article-title":"The role of multidisciplinary teams in neurorehabilitation: a systematic review","volume":"52","author":"Plant","year":"2020","journal-title":"J. Rehabil. Med."},{"key":"10.1016\/bs.pbr.2025.08.007_bib76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.irn.2021.06.006","article-title":"Adaptive deep brain stimulation (aDBS)","volume":"159","author":"Priori","year":"2021","journal-title":"Int. Rev. Neurobiol."},{"issue":"9","key":"10.1016\/bs.pbr.2025.08.007_bib77","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/mds.28097","article-title":"Integrated care in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"35","author":"Rajan","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2025.08.007_bib78","first-page":"141","article-title":"Depression in somatic disorders: is there a beneficial effect of exercise?","volume":"10","author":"Roeh","year":"2019","journal-title":"Front. Psychol."},{"issue":"25","key":"10.1016\/bs.pbr.2025.08.007_bib79","article-title":"Refining maximal heart rate estimation to enhance exercise recommendations for persons with Parkinson disease","author":"Rosenfeldt","year":"2025","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"9423","key":"10.1016\/bs.pbr.2025.08.007_bib80","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson\u2019s disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.007_bib81","first-page":"1211","article-title":"Correction of LRRK2 mutations in patient-derived iPSCs","volume":"25","author":"Sanders","year":"2017","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib82","first-page":"1","article-title":"Virtual reality-based neurorehabilitation for Parkinson\u2019s disease: a systematic review","volume":"19","author":"Santos","year":"2022","journal-title":"J. Neuroeng. Rehabil."},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.007_bib83","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/mds.27414","article-title":"Targeted therapies for Parkinson\u2019s disease: from genetics to the clinic","volume":"33","author":"Sardi","year":"2018","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/bs.pbr.2025.08.007_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015298","article-title":"Amantadine study group. Amantadine for dyskinesias in Parkinson\u2019s disease: a randomized controlled trial","volume":"5","author":"Sawada","year":"2010","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.007_bib85","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/NPT.0000000000000507","article-title":"Promoting physical activity in people with Parkinson\u2019s disease through a smartphone app: a pilot study","volume":"49","author":"Schootemeijer","year":"2025","journal-title":"J. Neurol. Phys. Ther."},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.007_bib86","first-page":"342","article-title":"Patient-centered care in Parkinson\u2019s disease: a systematic review","volume":"9","author":"Schrag","year":"2022","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.007_bib87","first-page":"342","article-title":"Personalized medicine in Parkinson\u2019s disease: a systematic review","volume":"9","author":"Schrag","year":"2022","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"7618","key":"10.1016\/bs.pbr.2025.08.007_bib88","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces abeta plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.007_bib89","first-page":"265","article-title":"Addressing phenoconversion: the achilles\u2019 heel of current pharmacogenomics","volume":"55","author":"Shah","year":"2015","journal-title":"J. Clin. Pharmacol."},{"issue":"14","key":"10.1016\/bs.pbr.2025.08.007_bib90","first-page":"4056","article-title":"Mitochondrial alterations in PARK2-associated Parkinson\u2019s disease","volume":"24","author":"Shaltouki","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/bs.pbr.2025.08.007_bib91","first-page":"33","article-title":"Update on ropinirole in the treatment of Parkinson\u2019s disease","volume":"5","author":"Shill","year":"2009","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/bs.pbr.2025.08.007_bib92","series-title":"StatPearls [Internet]","article-title":"Pramipexole [Internet]","author":"Singh","year":"2025"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib93","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/JPD-202279","article-title":"Infection and risk of Parkinson\u2019s disease","volume":"11","author":"Smeyne","year":"2021","journal-title":"J. Parkinson\u2019s Dis."},{"issue":"7601","key":"10.1016\/bs.pbr.2025.08.007_bib94","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature17939","article-title":"Parkinson-associated risk variant in distal enhancer of \u03b1-uclein modulates target gene expression","volume":"533","author":"Soldner","year":"2016","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2025.08.007_bib95","series-title":"StatPearls [Internet]","article-title":"Promethazine. [Updated 2024 Jan 1]","author":"Southard","year":"2025"},{"key":"10.1016\/bs.pbr.2025.08.007_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2025.143307","article-title":"Integration of volatile and nonvolatile metabolite profiles, and PPO activity reveals the methyl jasmonate protective advantage and metabolite characteristics of houttuynia cordata during storage","volume":"475","author":"Song","year":"2025","journal-title":"Food Chem."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib97","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41746-024-01175-9","article-title":"Identification of Parkinson\u2019s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data","volume":"7","author":"Su","year":"2024","journal-title":"NPJ Digit. Med."},{"key":"10.1016\/bs.pbr.2025.08.007_bib98","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1038\/s41598-025-85668-x","article-title":"Association between wide-ranging food intake and parkinson\u2019s disease: a comprehensive mendelian randomization study","volume":"15","author":"Su","year":"2025","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.007_bib99","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/bs11040054","article-title":"Treatment of Parkinson\u2019s disease with cognitive impairment: current approaches and future directions","volume":"11","author":"Sun","year":"2021","journal-title":"Behav. Sci."},{"key":"10.1016\/bs.pbr.2025.08.007_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2024.1531688","article-title":"Effectiveness of a home-based computerized cognitive training in Parkinson\u2019s disease: a pilot randomized cross-over study","volume":"15","author":"Tagliente","year":"2025","journal-title":"Front. Psychol."},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.007_bib101","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2025.08.007_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.14","article-title":"Normalization of overexpressed \u03b1-Synuclein causing Parkinson\u2019s disease by a moderate gene silencing with RNA interference","volume":"4","author":"Takahashi","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/bs.pbr.2025.08.007_bib103","article-title":"Efficacy of virtual reality-based cognitive behavioral group therapy in enhancing emotional well-being and quality of life in Parkinson\u2019s disease: a randomized controlled trial","volume":"12","author":"Tayyebi","year":"2025","journal-title":"Clin. Park. Relat. Disord."},{"key":"10.1016\/bs.pbr.2025.08.007_bib104","unstructured":"The National Collaborating Centre for Chronic Conditions ed. Parkinson\u2019s disease. London: Royal College of Physicians; 2006. Symptomatic pharmacological therapy in Parkinson\u2019s disease; pp. 59\u2013100. 1-86016-283-5."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib105","first-page":"1","article-title":"Principles and applications of adaptive deep brain stimulation in Parkinson\u2019s disease","volume":"12","author":"Thenaisie","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.007_bib106","article-title":"Multidisciplinary rehabilitation for acquired brain injury in adults of working age","volume":"2020","author":"Turner-Stokes","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/bs.pbr.2025.08.007_bib107","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.007_bib108","first-page":"537","article-title":"Using care bundles to improve patient-centered care in Parkinson\u2019s disease","volume":"10","author":"van der Eijk","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.007_bib109","first-page":"437","article-title":"Personalized treatment in Parkinson\u2019s disease: a systematic review","volume":"11","author":"van der Heeden","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"s1","key":"10.1016\/bs.pbr.2025.08.007_bib110","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3233\/JPD-202126","article-title":"Personalized care management for persons with Parkinson\u2019s disease","volume":"10","author":"Van Halteren","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.007_bib111","first-page":"855","article-title":"Human ESC-derived dopamine neurons function in a primate Parkinson\u2019s disease model","volume":"8","author":"Wang","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.007_bib112","first-page":"1","article-title":"Machine learning for neurorehabilitation: a review of the current state and future directions","volume":"19","author":"Wang","year":"2022","journal-title":"J. Neuroeng. Rehabil."},{"key":"10.1016\/bs.pbr.2025.08.007_bib113","series-title":"StatPearls [Internet]","article-title":"Tolcapone. [Updated 2023 Jul 10]","author":"Willman","year":"2025"},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.007_bib114","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/07317115.2019.1580811","article-title":"Telephone-delivered cognitive behavioural therapy for treating symptoms of anxiety and depression in Parkinson\u2019s disease: a pilot trial","volume":"42","author":"Wuthrich","year":"2019","journal-title":"Clin. Gerontologist"},{"key":"10.1016\/bs.pbr.2025.08.007_bib115","series-title":"Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects [Internet]. Brisbane (AU): Codon Publications","first-page":"7","article-title":"Pharmacological treatment of Parkinson\u2019s disease","author":"Zahoor","year":"2018"}],"container-title":["Progress in Brain Research","Precision Medicine in Neurodegenerative Diseases: From Research to Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612325001244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612325001244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:07:21Z","timestamp":1777939641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612325001244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443430114"],"references-count":115,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2025.08.007","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}